Individuals Stopping Slimming Jabs Regain Weight at a Quadrupled Rate Compared to Those on Conventional Diets

Fresh analysis indicates that patients who discontinue popular GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds far faster than those who end conventional diet and exercise programs.

Findings released in a prominent health publication shows that while overweight individuals frequently drop a large proportion of their body weight while on the medication, the mass returns at an estimated rate of 0.8 kg per month after stopping.

"People buying these treatments must be cognizant of the danger of quick rebound weight gain when the therapy concludes," stated lead investigator Dr. Susan Jebb.

This pace of regain suggests a return to original weight within about one and a half years.

Comparing Treatments

The study, which reviewed 37 of trials involving thousands of participants, contrasted the effects of these new drugs with other pills.

The team point out that individuals who shed pounds through diet and exercise generally experience a slower creep back—approximately 100 grams monthly—after stopping.

Explaining the Fast Regain

Nutrition scientists propose the mechanism of the injections accounts for the amplified regain.

These medications copy a natural hormone called GLP-1, which controls hunger.

"Sustained high doses of the hormone concentrations several times higher than normal might result in the system to generate a reduced amount of its own natural GLP-1, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a dietetics researcher.

"Stopping of this medication results in appetite is unsuppressed, making overeating far more likely."

A Chronic Condition?

The NHS advise the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.

Professionals contend that, considering the likelihood of relapse, the treatment is often long-term.

This perspective is echoed by pharmaceutical companies, who say that the findings "highlight the chronic nature of obesity," akin to managing diseases like hypertension.

Patient Testimonies

Individuals who have stopped the medication describe a intense resurgence of cravings.

"It felt as if a trigger that goes on and you become starving," recalled an individual.

This difficulty is compounded if patients have not adopted permanent lifestyle or habit changes during treatment.

Significant Use

Figures suggest that millions of people in the UK have tried weight-loss jabs in the past year, with desire remaining high.

• Adoption is greater among women than men.
• The 40s and 50s age group shows the highest usage rates.
• A large proportion access the drugs through private prescriptions rather than public health services.

Ultimately, experts caution that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent cure and lasting health benefits hinges on ongoing behavioural management.